SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc

Bullboard Posts

Post by FactFinder1994on Jul 23, 2020 9:17am

177 Views

Post# 31306621

Investor Presentation

Although the Investor Presentation was last updated in May, it is well worth digesting. The numbers presented often only touch on one market vs the global market, and are therefore overly conservative in nature. As it stands today, this company should have a 9 figure market cap, and is significantly undervalued. This could easily gap up by multiples of current value on almost nothing.
If you understand what you are reading in the Investor Presentation it will stimulate you to dig deeper. Stay tuned!

Bullboard Posts

Golden Minerals closes Yoquivo gold-silver project sale